Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/34079
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBATEN, Evert-
dc.contributor.authorVan der Aa, F.-
dc.contributor.authorGOETHUYS, Hans-
dc.contributor.authorSlabbert, K.-
dc.contributor.authorARIJS, Ingrid-
dc.contributor.authorVAN RENTERGHEM, Koenraad-
dc.date.accessioned2021-05-26T13:11:41Z-
dc.date.available2021-05-26T13:11:41Z-
dc.date.issued2021-
dc.date.submitted2021-05-25T12:44:56Z-
dc.identifier.citationWORLD JOURNAL OF UROLOGY, 39(10), p. 3839-3844-
dc.identifier.urihttp://hdl.handle.net/1942/34079-
dc.description.abstractPurpose To determine whether omitting antimicrobial prophylaxis (AMP) in TURB is safe in patients undergoing TURB without an indwelling pre-operative catheter/nephrostomy/DJ and a negative pre-operative urinary culture. Materials and methods A multi-centered randomized controlled trial (RCT) from 17-09-2017 to 31-12-2019 in 5 hospitals. Patients with a pre-operative indwelling catheter/DJ-stent or nephrostomy and a positive pre-operative urinary culture (> 10(4) uropathogens/mL) were excluded. Post-operative fever was defined as body temperature >= 38.3 degrees C. A non-inferiority design with a 6% noninferiority margin and null hypothesis (H0) that the infection risk is at least 6% higher in the experimental (E) than in the control (C) group; H0: C (AMP-group) - E (no AMP-group) >= Delta (6% noninferiority margin). A multivariable, logistic regression was performed for AMP and post-TURB fever with covariates: tumor size and (clot-) retention. The R Project(R) for statistical computing was used for statistical analysis and a p value of 0.05 was considered as statistically significant. Results 459 Patients were included and 202/459 (44.1%) received AMP vs 257/459 (55.9%) without AMP. Fever occurred in 6/202 [2.9%; 95% CI (1.2-6.6%)] patients with AMP vs 8/257 [3.1%; 95% CI (1.5%-6.1%)] without AMP (p = 0.44). Multivariable, logistic regression showed no significant harm in omitting AMP when controlled for (clot-)retention and tumor size (p = 0.85) and an adjusted risk difference in developing post-TURB fever of 0.0016; 95% CI [- 0.029; 0.032]. Conclusion Our data suggest the safety of omitting AMP in patients undergoing TURB without an indwelling, pre-operative catheter/nephrostomy/DJ and a negative pre-operative urinary culture.-
dc.language.isoen-
dc.publisherSPRINGER-
dc.rights© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021-
dc.subject.otherTURB-
dc.subject.otherAMP-
dc.subject.otherMicrobial resistance-
dc.subject.otherRCT-
dc.subject.otherFever-
dc.subject.otherAntimicrobial stewardship-
dc.titleA randomized trial regarding antimicrobial prophylaxis (AMP) in transurethral resection of bladder tumor (TURB)-
dc.typeJournal Contribution-
dc.identifier.epage3844-
dc.identifier.issue10-
dc.identifier.spage3839-
dc.identifier.volume39-
local.format.pages6-
local.bibliographicCitation.jcatA1-
dc.description.notesBaten, E (corresponding author), Associatie Urol Hageland, Kapellekensweg 10, Kessel Lo, Belgium.; Baten, E (corresponding author), Univ Hasselt, Martelarenlaan 45, B-3050 Hasselt, Belgium.-
dc.description.notesEvert.baten@gmail.com-
dc.description.otherBaten, E (corresponding author), Associatie Urol Hageland, Kapellekensweg 10, Kessel Lo, Belgium ; Univ Hasselt, Martelarenlaan 45, B-3050 Hasselt, Belgium. Evert.baten@gmail.com-
local.publisher.placeONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1007/s00345-021-03694-6-
dc.identifier.isiWOS:000639060800002-
local.provider.typewosris-
local.uhasselt.uhpubyes-
local.description.affiliation[Baten, E.; Slabbert, K.] Associatie Urol Hageland, Kapellekensweg 10, Kessel Lo, Belgium.-
local.description.affiliation[Van der Aa, F.; van Renterghem, K.] Univ Hosp Leuven, Dept Urol, Herestr 49, B-3000 Leuven, Belgium.-
local.description.affiliation[Goethuys, H.] ZOL Genk, Genk, Belgium.-
local.description.affiliation[Arijs, I] VIB, Ctr Canc Biol, B-3000 Leuven, Belgium.-
local.description.affiliation[Baten, E.; van Renterghem, K.] Univ Hasselt, Martelarenlaan 45, B-3050 Hasselt, Belgium.-
local.description.affiliation[van Renterghem, K.] Jessa Ziekenhuis, Dient Urol, Salvatorstr 20, B-3500 Hasselt, Belgium.-
local.uhasselt.internationalno-
item.contributorBATEN, Evert-
item.contributorVan der Aa, F.-
item.contributorGOETHUYS, Hans-
item.contributorSlabbert, K.-
item.contributorARIJS, Ingrid-
item.contributorVAN RENTERGHEM, Koenraad-
item.fullcitationBATEN, Evert; Van der Aa, F.; GOETHUYS, Hans; Slabbert, K.; ARIJS, Ingrid & VAN RENTERGHEM, Koenraad (2021) A randomized trial regarding antimicrobial prophylaxis (AMP) in transurethral resection of bladder tumor (TURB). In: WORLD JOURNAL OF UROLOGY, 39(10), p. 3839-3844.-
item.accessRightsRestricted Access-
item.fulltextWith Fulltext-
item.validationecoom 2022-
crisitem.journal.issn0724-4983-
crisitem.journal.eissn1433-8726-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
s00345-021-03694-6.pdf
  Restricted Access
Published version561.65 kBAdobe PDFView/Open    Request a copy
Show simple item record

WEB OF SCIENCETM
Citations

1
checked on Apr 30, 2024

Page view(s)

40
checked on Sep 7, 2022

Download(s)

10
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.